These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 19327730)
21. Notch signaling, gamma-secretase inhibitors, and cancer therapy. Shih IeM; Wang TL Cancer Res; 2007 Mar; 67(5):1879-82. PubMed ID: 17332312 [TBL] [Abstract][Full Text] [Related]
22. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents. Grippo PJ; Sandgren EP Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988 [TBL] [Abstract][Full Text] [Related]
23. Conversion of non-endocrine human pancreatic cells to insulin-producing cells for treatment of diabetes. Zhao M; Huang GC Methods Mol Biol; 2012; 806():73-85. PubMed ID: 22057446 [TBL] [Abstract][Full Text] [Related]
24. Reprogramming of human exocrine pancreas cells to beta cells. Staels W; Heremans Y; Heimberg H Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):849-57. PubMed ID: 26696514 [TBL] [Abstract][Full Text] [Related]
27. [Inhibitors for Notch and gamma-secretase. Biology of T-cell leukemia]. Yahagi Y; Usui N Gan To Kagaku Ryoho; 2009 May; 36(5):744-8. PubMed ID: 19496283 [No Abstract] [Full Text] [Related]
28. COUP-TFI controls Notch regulation of hair cell and support cell differentiation. Tang LS; Alger HM; Pereira FA Development; 2006 Sep; 133(18):3683-93. PubMed ID: 16914494 [TBL] [Abstract][Full Text] [Related]
29. Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110α. Baer R; Cintas C; Dufresne M; Cassant-Sourdy S; Schönhuber N; Planque L; Lulka H; Couderc B; Bousquet C; Garmy-Susini B; Vanhaesebroeck B; Pyronnet S; Saur D; Guillermet-Guibert J Genes Dev; 2014 Dec; 28(23):2621-35. PubMed ID: 25452273 [TBL] [Abstract][Full Text] [Related]
30. [Symptoms, clinical findings and laboratory data in the pancreatic ductal adenocarcinoma]. Hatori T; Doi M; Yamamoto M Nihon Rinsho; 2015 Mar; 73 Suppl 3():106-9. PubMed ID: 25856995 [No Abstract] [Full Text] [Related]
31. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model. Efferson CL; Winkelmann CT; Ware C; Sullivan T; Giampaoli S; Tammam J; Patel S; Mesiti G; Reilly JF; Gibson RE; Buser C; Yeatman T; Coppola D; Winter C; Clark EA; Draetta GF; Strack PR; Majumder PK Cancer Res; 2010 Mar; 70(6):2476-84. PubMed ID: 20197467 [TBL] [Abstract][Full Text] [Related]
32. [Actual problems of biology of pancreatic acino-insular cells]. Iaglov VV; Iaglova NV Vestn Ross Akad Med Nauk; 2010; (7):28-35. PubMed ID: 20795400 [TBL] [Abstract][Full Text] [Related]
33. Primers on molecular pathways--notch. Lomberk G; Urrutia R Pancreatology; 2008; 8(2):103-4. PubMed ID: 18382095 [TBL] [Abstract][Full Text] [Related]
34. CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma. Teodorczyk M; Kleber S; Wollny D; Sefrin JP; Aykut B; Mateos A; Herhaus P; Sancho-Martinez I; Hill O; Gieffers C; Sykora J; Weichert W; Eisen C; Trumpp A; Sprick MR; Bergmann F; Welsch T; Martin-Villalba A Cell Death Differ; 2015 Jul; 22(7):1192-202. PubMed ID: 25613377 [TBL] [Abstract][Full Text] [Related]
35. The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma. Martínez-Romero C; Rooman I; Skoudy A; Guerra C; Molero X; González A; Iglesias M; Lobato T; Bosch A; Barbacid M; Real FX; Hernández-Muñoz I J Pathol; 2009 Oct; 219(2):205-13. PubMed ID: 19585519 [TBL] [Abstract][Full Text] [Related]
36. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease. Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883 [TBL] [Abstract][Full Text] [Related]
38. Lineage tracing evidence for transdifferentiation of acinar to duct cells and plasticity of human pancreas. Houbracken I; de Waele E; Lardon J; Ling Z; Heimberg H; Rooman I; Bouwens L Gastroenterology; 2011 Aug; 141(2):731-41, 741.e1-4. PubMed ID: 21703267 [TBL] [Abstract][Full Text] [Related]
39. Development of the pancreas and pancreatic cancer. Lewis BC Endocrinol Metab Clin North Am; 2006 Jun; 35(2):397-404, xi. PubMed ID: 16632101 [TBL] [Abstract][Full Text] [Related]
40. Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression. Aguilar S; Corominas JM; Malats N; Pereira JA; Dufresne M; Real FX; Navarro P Am J Pathol; 2004 Oct; 165(4):1129-39. PubMed ID: 15466380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]